Four women and three men after allogeneic (n ¼ 4) and autologous (n ¼ 3) haematopoietic SCT (HSCT) were observed to have an increase in T-cell large granular lymphocytes (T-LGLs) of CD3 þ CD8 þ phenotype for a median of 41 (15 --118) months. Clonal rearrangement of the T-cell receptor gene was verified by two PCR techniques and direct DNA sequencing, confirming that the cases were neoplastic and therefore classifiable as T-LGL leukaemia. In the allogeneic HSCT cases, T-LGL leukaemia was derived from donor T cells in three patients, as shown by DNA chimerism analysis, and recipient T cells in one patient who had graft failure previously. None of the patients showed cytopenia, autoimmune phenomenon or organ infiltration, which were features typical of de novo T-LGL leukaemia. Six patients had remained asymptomatic with stable large granular lymphocyte counts. One patient died from cerebral relapse of the original lymphoma. T-LGL leukaemias occurring post-HSCT are distinct from de novo T-LGL leukaemia and may have a different pathogenesis and clinical course. Patients did not require specific treatment, and the disease remained stable for long periods.Bone Marrow Transplantation (2012) 47, 952 --956;
A 52-year-old woman presented with unremitting pyrexia reaching 40C. There was progressive weight loss and jaundice. A series of investigations failed to give a diagnosis, and because of rapid deterioration she was referred for management. On admission, she was moribund, with a fever of 40 C. There was marked pallor and jaundice. Abdominal examination showed gross hepatomegaly and splenomegaly (22 cm and 6 cm below the costal margin, respectively). A full blood count showed hemoglobin: 5.5 g/dL, white cell count: 1.42
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.